Drug discovery platform developer Compugen Ltd. almost quadrupled its revenue to $800,000 for the second quarter of 2010 from $225,000 for the corresponding quarter of 2009 thanks to the recognition of initial fees and research revenues from collaborative ventures.
Compugen quadruples revenue